Screen Reader Access

Drug Pipeline (Small molecule)

Candidate Drug/Lead Compound Indication Lead Optimization IND Enabling IND Filed Phase I Phase II Phase III
Umifenovir
(Licensed) 		 COVID-19
S-007-867
(Licensed) 		 Thrombosis
S-007-1500
(Licensed) 		 Fracture healing
L-Ormeloxifene
(Licensed) 		 Female contraceptive
S-011-1793 Malaria
96-261 Leishmaniasis
SB-CDRI4-105 Chemotherapy induced neuropathic pain
GS/IICT5-6 Cancer
S-016-1348 Colon cancer
S-016-1271 Complicated UTI
S-017-622 Hyperlipidemia